Bunge Global SA - Q2 2024 10-Q Summary
Business Context and Reporting Period
This filing covers the quarterly period ended June 30, 2024. Bunge Global SA is a global agribusiness company organized into four reportable segments: Agribusiness, Refined and Specialty Oils, Milling, and Sugar and Bioenergy. The company is currently pursuing a definitive business combination with Viterra Limited, expected to close in the coming months.
Key Financial Metrics
| Metric (in millions, except per share) | Q2 2024 | Q2 2023 | YTD 2024 | YTD 2023 |
|---|---|---|---|---|
| Net Sales | $13,241 | $15,049 | $26,658 | $30,377 |
| Gross Profit | $664 | $1,365 | $1,540 | $2,546 |
| Net Income (Attributable to Bunge) | $70 | $622 | $314 | $1,254 |
| Diluted EPS | $0.48 | $4.09 | $2.17 | $8.24 |
| Total Segment EBIT | $185 | $912 | $618 | $1,798 |
| Cash from Operating Activities (YTD) | ($480) | $472 | ($480) | $472 |
| Total Debt | $5,040 | $4,949 | $5,040 | $4,949 |
| Working Capital | $7,846 | $8,909 | $7,846 | $8,909 |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 12% in Q2 and 12% YTD compared to the prior year, primarily driven by lower average sales prices across Agribusiness and Refined and Specialty Oils segments due to market price stabilization and increased supply.
- Profitability Compression: Net income attributable to Bunge dropped 89% in Q2 and 75% YTD. Total Segment EBIT fell 80% in Q2 and 66% YTD. The Agribusiness segment EBIT declined 82% in Q2 due to lower gross margins in soybean oilseed processing.
- Cash Flow Reversal: Operating cash flow turned negative, using $480 million YTD 2024 compared to generating $472 million in YTD 2023. This was driven by lower net income and increased cash usage for working capital (inventory build-up for the South American harvest) despite lower commodity prices.
- Foreign Exchange Impact: The company recorded a foreign exchange loss of $103 million on net debt for the six months ended June 30, 2024, compared to a gain of $174 million in the prior year period.
Guidance, Outlook, and Risks
- Viterra Acquisition: Bunge has secured $8.0 billion in acquisition financing for the Viterra deal. The transaction is subject to regulatory approvals and is expected to close in the next several months. A termination fee of $400 million is payable if the deal fails due to antitrust issues.
- Divestitures: Bunge agreed to sell its 50% stake in BP Bunge Bioenergia for approximately $800 million (expected Q4 2024 close) and 40% of Bunge Iberica SA for $300 million plus contingent payments (expected late 2024 close).
- Capital Allocation: The company repurchased $400 million of shares in the first half of 2024. A $1.0 billion capacity remains under the share repurchase program. Shareholders approved a $2.72 per share annual dividend distribution.
- Risks: Key risks include the impact of the war in Ukraine, global economic conditions, commodity price volatility, and the successful integration of the Viterra acquisition. Credit ratings remain stable with positive outlooks from major agencies pending the acquisition closing.
Investor Verification Checklist
- Working Capital Dynamics: Verify the sustainability of the negative operating cash flow given the seasonal inventory build-up and lower margins.
- Margin Recovery: Monitor the Agribusiness segment's ability to recover gross margins as commodity price spreads stabilize.
- Viterra Closing: Track regulatory approval progress for the Viterra acquisition and potential changes to the transaction consideration based on share price.
- Foreign Exchange Exposure: Assess the impact of currency fluctuations, particularly the Brazilian Real and U.S. Dollar, on debt servicing and earnings.
- Divestiture Execution: Confirm the timing and final proceeds from the BP Bunge Bioenergia and Bunge Iberica sales.